Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lau David CW"'
Autor:
Courneya Kerry S, Vallance Jeff K, Culos-Reed S, McNeely Margaret L, Bell Gordon J, Mackey John R, Yasui Yutaka, Yuan Yan, Matthews Charles E, Lau David CW, Cook Diane, Friedenreich Christine M
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 525 (2012)
Abstract Background Limited research has examined the association between physical activity, health-related fitness, and disease outcomes in breast cancer survivors. Here, we present the rationale and design of the Alberta Moving Beyond Breast Cancer
Externí odkaz:
https://doaj.org/article/ae494ec9090340cf81aeadf99e0d4718
Autor:
O'Neil, Patrick M, Aroda, Vanita R, Astrup, Arne, Kushner, Robert, Lau, David CW, Wadden, Thomas A, Brett, Jason, Cancino, Ana-Paula, Wilding, John PH, Adiposity, Satiety Clinical
Publikováno v:
Diabetes, Obesity & Metabolism
DIABETES OBESITY & METABOLISM
O'Neil, P M, Aroda, V R, Astrup, A, Kushner, R, Lau, D C W, Wadden, T A, Brett, S J, Cancino, A, Wilding, J P H & Satiety and Clinical Adiposity-Liraglutide Evidence in individuals with and without diabetes (SCALE) study groups 2017, ' Neuropsychiatric safety with liraglutide 3.0 mg for weight management : Results from randomized controlled phase 2 and 3a trials ', Diabetes, Obesity and Metabolism, vol. 19, no. 11, pp. 1529-1536 . https://doi.org/10.1111/dom.12963
DIABETES OBESITY & METABOLISM
O'Neil, P M, Aroda, V R, Astrup, A, Kushner, R, Lau, D C W, Wadden, T A, Brett, S J, Cancino, A, Wilding, J P H & Satiety and Clinical Adiposity-Liraglutide Evidence in individuals with and without diabetes (SCALE) study groups 2017, ' Neuropsychiatric safety with liraglutide 3.0 mg for weight management : Results from randomized controlled phase 2 and 3a trials ', Diabetes, Obesity and Metabolism, vol. 19, no. 11, pp. 1529-1536 . https://doi.org/10.1111/dom.12963
AIMS: Liraglutide, a GLP-1 receptor agonist, regulates appetite via receptors in the brain. Due to concerns over the potential of centrally-acting anti-obesity medications to affect mental health, pooled neuropsychiatric safety data from all phase 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4a02de7c87cdfb20c142436df424b46
https://pubmed.ncbi.nlm.nih.gov/28386912
https://pubmed.ncbi.nlm.nih.gov/28386912